Zimmer Biomet, InMode And The World’s Largest Investment Firm: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Zimmer Biomet Holdings, Inc.
Cramer: This Healthcare Stock Is A ‘Screaming Buy.’ As For Annaly? ‘It’s A Trap’
GE HealthCare Technologies Inc.
Why This Analyst Raised Maxeon Solar Technologies Forecast By Almost 100%
Maxeon Solar Technologies Ltd (NASDAQ: MAXN) shares climbed in early trading on Wednesday, on news that the company and Samsung Electronics Ltd. (OTC: SSNLF)
5 Analysts Takeaways From The Advanced Micro Devices Data Center And AI Technology Event
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) rose in early trading on Wednesday, after the company held on Tuesday its key Data Center and AI Technologies event.
2 Strong Endpoint Security Stocks: Which One To Buy?
The global cybersecurity market remains in focus, as news of cyber threat and hacked accounts grab headlines.
Morgan Stanley, IBM And A Big 3 Automaker That’s Buying Back Shares: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said General Motors Company (NYSE: GM) has got cash flows and is also
Bullish Shadows Over SPY, Bearish Vibes For QQQ: Options Activity Signals Mixed Market Sentiment Pre-Fed Announcement
Overall market sentiment was mixed ahead of Wednesday’s Fed announcement on its interest rate decision.
Oracle Exhibits Strong And Sustained Cloud Momentum: 5 Wall Street Analysts React To FQ4 Results
Shares of Oracle Corporation (NYSE: ORCL) climbed in early trading on Monday, after the company reported better-than-expected results for its fiscal fourth quarter.
Goldman Sachs Upgrades Devon Energy, But Is Less Bullish On EOG Resources: Here’s Why
U.S. exploration and production (E&P) companies have underperformed other energy stocks so far this year due to higher costs driven by inflation and weaker oil and gas prices.
AbbVie, Deere And A Major Chipmaker Set To Win In AI: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said AbbVie Inc.